PSTX Past Earnings image   This PSTX past earnings page last updated 11/11/2022
PSTX Past Earnings
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.920
Q2 20228/11/2022-0.690
Q1 20225/12/2022-0.930
Q4 20213/10/20220.020
Q3 202111/9/2021-0.680
Q2 20218/12/2021-0.740
Q1 20215/11/2021-0.620
Q4 20203/11/2021-0.580
Q3 202011/12/2020-0.630
Q2 20208/20/2020-2.280
PSTX Past Revenue
PeriodPast Earnings DateGAAP
Q3 202211/10/20220.12B
Q2 20228/11/20220.00B
Q1 20225/12/20220.00B
Q4 20213/10/2022NA
Q3 202111/9/2021NA
Q2 20218/12/2021NA
Q1 20215/11/2021NA
Q4 20203/11/2021NA
Q3 202011/12/2020NA
Q2 20208/20/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree PSTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Poseida Therapeutics (PSTX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

PTCT Past Earnings
PTE Past Earnings
PTGX Past Earnings
PTIX Past Earnings
PTPI Past Earnings
PULM Past Earnings
QDEL Past Earnings
QLGN Past Earnings
QNCX Past Earnings
QTRX Past Earnings

PSTX Past Earnings Q&A

What was the best and worst PSTX past earnings results?
For Poseida Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest PSTX past earnings result in our data set was 0.920/share posted in Q3 2022, while the lowest was in Q2 2020 when PSTX posted -2.280/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2022 when PSTX reported 0.12B in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at NA of revenue.

  Suggested answer: There are 10 PSTX past earnings results in our data set.

On this page we presented the PSTX past earnings date information for Poseida Therapeutics. Reviewing that PSTX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2022, when PSTX posted gaap of 0.920/share. Meanwhile the lowest PSTX past earnings result was in Q2 2020, when PSTX posted gaap of -2.280/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2022 when PSTX reported 0.12B in revenue, while the smallest revenue quarter was Q4 2021 when PSTX reported NA in revenue.

Any self directed investor doing their due diligence on PSTX or any other given stock can benefit from researching all of the Poseida Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Poseida Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for PSTX. Thanks for visiting, and the next time you need to research PSTX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: IDT Historical Stock Prices, TTI Split History, HUGE Options Chain.


PSTX Past Earnings | | Copyright © 2020 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.